PUMA BIOTECHNOLOGY, INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Sep 2017 | 74.9% | -1,274.3% | -1,270.0% |
| Dec 2017 | — | — | -296.5% |
| Mar 2018 | 90.4% | -35.2% | -36.6% |
| Jun 2018 | 82.6% | -81.6% | -87.3% |
| Sep 2018 | 85.6% | -18.0% | -22.7% |
| Dec 2018 | — | — | -43.2% |
| Mar 2019 | 91.9% | 9.9% | -10.2% |
| Jun 2019 | 82.7% | -47.8% | -69.4% |
| Sep 2019 | — | -25.6% | -30.0% |
| Dec 2019 | — | — | -17.8% |
| Mar 2020 | — | -27.8% | -33.1% |
| Jun 2020 | — | 10.1% | 4.8% |
| Sep 2020 | 80.4% | -23.9% | -62.0% |
| Dec 2020 | — | — | -28.5% |
| Mar 2021 | 69.9% | 20.5% | 16.8% |
| Jun 2021 | 77.6% | -31.2% | -9.6% |
| Sep 2021 | 77.8% | -19.4% | -96.6% |
| Mar 2022 | 76.3% | -1.6% | -7.4% |
| Jun 2022 | 74.9% | 20.3% | 15.7% |
| Sep 2022 | 78.1% | 4.2% | -0.6% |
| Mar 2023 | 75.0% | 8.3% | 2.7% |
| Jun 2023 | 78.3% | 9.0% | 3.9% |
| Sep 2023 | 76.3% | 15.3% | 10.3% |
| Mar 2024 | 75.5% | -5.3% | -11.0% |
| Jun 2024 | 77.4% | -4.6% | -9.6% |
| Sep 2024 | 63.9% | 27.4% | 25.2% |
| Mar 2025 | 77.1% | 8.7% | 6.5% |
| Jun 2025 | 76.5% | 12.7% | 11.2% |
| Sep 2025 | 77.7% | 17.6% | 16.2% |
| Mar 2026 | 76.7% | -8.5% | -8.4% |
| Jun 2026 | 77.9% | 13.4% | 14.5% |